Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial (Clinical Rheumatology, (2018), 37, 12, (3285-3296), 10.1007/s10067-018-4227-7)

J. A. Walsh, A. B. Gottlieb, B. Hoepken, T. Nurminen, P. J. Mease

Research output: Contribution to journalComment/debate

Abstract

The above article originally published with an error present in Discussion section and presented correctly in this article. The original article was corrected.

Original languageEnglish
Pages (from-to)3297
Number of pages1
JournalClinical Rheumatology
Volume37
Issue number12
DOIs
StatePublished - 1 Dec 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial (Clinical Rheumatology, (2018), 37, 12, (3285-3296), 10.1007/s10067-018-4227-7)'. Together they form a unique fingerprint.

Cite this